News

In 2018, Mary Jo Dorotinsky learned she had cancer in her right breast. “I actually went in for a mammogram a few months late when they discovered a very small tumor,” Mary Jo said. “It felt like fate. The doctor told me that if I had gone in on schedule, they might have missed the lump because it was so small.” Mary Jo had a lumpectomy and traditional photon radiation to treat the stage one cancer.  When her treatments were over, her doctor recommended Mary Jo alternate between a mammogram and MRI...

Patient Power Currently, multiple myeloma (MM) is uncurable, so oncologists try to find treatment options that will control the disease. Abhinav Deol, M.D. , hematologist, medical oncologist, and member of the  Bone Marrow and Stem Cell Transplant ,  Hematology Oncology  and  Multiple Myeloma and Amyloidosis  Multidisciplinary Teams at Karmanos, explained the success rates for using CAR T cell therapy to treat MM or stem cell transplantation. Read the article here .

The Detroit News The TheraBionic P1 device is now available for patients who have advanced liver cancer and have failed first- and second-line therapies. Boris Pasche, M.D., Ph.D., FACP , president and CEO of the Barbara Ann Karmanos Cancer Institute, chair of the Department of Oncology at Wayne State University, and co-inventor of the TheraBionic P1 device, and Anthony Shields, M.D., Ph.D. , medical oncologist and member of the  Gastrointestinal and Neuroendocrine Oncology Multidisciplinary Team ,...

The Barbara Ann Karmanos Cancer Institute , the largest provider of cancer care and research in Michigan and part of McLaren Health Care, announced today that the new TheraBionic P1 device, an FDA-approved, at-home treatment , is now available to treat advanced liver cancer. Karmanos Cancer Center is the first institution worldwide to prescribe this treatment. The TheraBionic P1 device is a novel, handheld, portable device that produces low levels of 27.12 MHz radiofrequency electromagnetic fields, whic...

On Wednesday, Dec. 4, 2024, patients, survivors, and advocates gathered at Karmanos Cancer Institute in Detroit to learn about metastatic breast cancer, including initial and ongoing treatments, biomarkers and overall treatment strategies. Organized by CURE in collaboration with the Office of Cancer Health Equity and Community Engagement (OCHECE) at Karmanos, this event provided an opportunity for community members to engage with experts in metastatic breast cancer, enhancing their understanding of trea...

To celebrate Breast Cancer Awareness Month, a unique mobile entertainment company, Paint’d Party Services, decided to help bring some joy to cancer survivors by donating painting kits, an item used frequently by the Barbara Ann Karmanos Cancer Institute’s Healing Arts Program.  “Donations like these are instrumental in making sure we can help create joy in the lives of cancer survivors,” said Greg Cascione, Ph.D., philanthropy officer at Karmanos. “Being able to provide these activities and experie...

WDET A foundation will offer scholarships and internships to medical students for assistance in recruiting underrepresented and disadvantaged individuals into clinical trials. Hayley Thompson, Ph.D., associate center director of Community Outreach and Education at Karmanos Cancer Institute and faculty supervisor of Karmanos’ Office of Cancer Health Equity and Community Engagement , applauded this work and explained why it's important for patients of color to consider participating in clinical trials. Sh...

Your genes determine your eye color and height, and they may also reveal your cancer risk. Having a family history of certain types of cancer can increase your risk of developing the disease. There is a lot of information out there about genetics and cancer risk, and sifting through it can be overwhelming and confusing. But you don’t have to do it alone. The Karmanos Cancer Institute genetic counseling service is available to patients throughout the Karmanos Cancer Network. “Genetic counselors have adva...

Patient Power Yusra Shao, M.D. , medical oncologist and member of the  Genitourinary Oncology Multidisciplinary Team  at Karmanos, explained how immune checkpoint inhibitors work when treating bladder cancer, and the response rate for this therapy. Read the article here .

Patient Power Amina Pervaiz, M.D. , pulmonologist and member of the Thoracic Oncology Multidisciplinary Team at Karmanos, discussed risk factors for developing a solitary pulmonary nodule. Though the majority are not cancerous, these nodules can be detected through imaging and are usually a round lesion of less than three centimeters in diameter. Read the article here .